Metastatic cutaneous squamous cell carcinoma: An update

Dermatologic Surgery

Volumn 33, Issue 8, 2007, Pages 885-899

  Weinberg, Aaron S ^b   Ogle, Christina A ^b   Shim, Elisabeth K ^a,b  

^a St John's Medical Plaza ^*  (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CAPECITABINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; IMIQUIMOD; INTERFERON; ISOTRETINOIN; METHOTREXATE; RETINOIC ACID;

CANCER CHEMOTHERAPY; CANCER PREVENTION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; METASTASIS; PRIORITY JOURNAL; RADIODIAGNOSIS; RECURRENT DISEASE; REVIEW; RISK FACTOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; NEOPLASM STAGING; RISK FACTORS; SKIN NEOPLASMS; SURVIVAL RATE;

EID: 34547128098     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2007.33190.x     Document Type: Review

References (100)

1. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992 26 : 467 84.
2. Hampton T. Skin cancer's ranks rise. Immunosuppression to blame. JAMA 2005 294 : 1476 80.
3. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005 294 : 681 90.
4. Epstein E, Epstein NN, Bragg K, Linden G. Metastases from squamous cell carcinomas of the skin. Arch Dermatol 1968 97 : 245 9.
5. Dinehart SM, Pollack SV. Metastases from squamous cell carcinoma of the skin and lip: an analysis of twenty-seven cases. J Am Acad Dermatol 1989 21 (2 Pt 1) : 241 8.
6. Rowe DE, Carroll RJ, Day CL. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. J Am Acad Dermatol 1992 26 : 976 90.
7. Chuang TY, Popescu NA, Su PD, Chute CG. Squamous cell carcinoma: a population-based incidence study in Rochester, MN. Arch Dermatol 1990 126 : 185 8.
8. Tavin E, Persky M. Metastatic cutaneous squamous cell carcinoma of the head and neck region. Laryngoscope 1996 106 (2 Pt 1) : 156 8.
9. Kraus DH, Carew JF, Harrison LB. Regional lymph node metastasis from cutaneous squamous cell carcinoma. Arch Otolaryngol 1998 124 : 582 7.
10. Frierson HF, Cooper PH. Prognostic factors in squamous cell carcinoma of the lower lip. Human Pathol 1986 17 : 346 54.
11. de Vries NC. Metastases of squamous cell carcinoma of the skin and lip. Dermatologica 1969 138 : 333 9.
12. Katz AD, Urbach F, Lilienfeld AM. The frequency and risk of metastases in squamous cell carcinoma of the skin. Cancer 1957 10 : 1162 6.
13. Lund HZ. How often does squamous cell carcinoma of the skin metastasize? Arch Dermatol 1965 92 : 635 7.
14. Durkovsky J, Krajci M, Michalikova B. To the problem of the lip cancer metastases. Neoplasma 1972 19 : 653 9.
15. Netterville JL, Sinard RJ, Bryant GL Jr., Burkey BB. Delayed regional metastasis from midfacial squamous carcinoma. Head Neck 1998 20 : 329 33.
16. Talmi YP, Horowitz Z, Wolf M, Kronenberg J. Delayed metastases in skin cancer of the head and neck: the case of the "known primary Ann Plast Surg 1999 42 : 289 92.
17. Brodland DG, Zitelli JA. Mechanisms of metastasis. J Am Acad Dermatol 1992 27 : 1 8.
18. Nicholson GL, Poste G. Tumor implantation and invasion at metastatic sites. Int Rev Exp Pathol 1983 22 : 77 181.
19. Khurana VG, Mentis DH, O'Brien CJ, et al. Parotid and neck metastases from cutaneous squamous cell carcinoma of the head and neck. Am J Surg 1995 170 : 446 50.
20. Clayman GL, Lee JJ, Holsinger FC, et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 2005 23 : 759 65.
21. Dean AL. Epithelioma of scrotum. J Urol 1948 60 : 508 18.
22. McQuarrie HB, Buie LA. Epithelioma of the anus. Postgrad Med 1950 7 : 402 9.
23. Staubitz WJ, Lent MH, Oberkircher OJ. Carcinoma of the penis. Cancer 1955 8 : 371 8.
24. Lewis KG, Weinstock MA. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study. Arch Dermatol 2004 140 : 837 42.
25. Breuninger H, Black B, Rassner G. Microstaging of squamous cell carcinomas. Am J Clin Pathol 1990 94 : 624 7.
26. Daniele E, Rodolico V, Leonardi V, Tralongo V. Prognosis in lower lip squamous cell carcinoma: assessment of tumor factors. Pathol Res Pract 1998 194 : 319 24.
27. Breuninger H, Schaumburg-Lever G, Holzschuh J, Horny HP. Desmoplastic squamous cell carcinoma of skin and vermilion surface. Cancer 1997 79 : 915 9.
28. Friedman HI, Cooper PH, Wanebo HJ. Prognostic and therapeutic use of microstaging of cutaneous squamous cell carcinoma of the trunk and extremities. Cancer 1985 56 : 1099 105.
29. Pentenero M, Gandolfo S, Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 2005 27 : 1080 91.
30. Evans HL, Smith JL. Spindle cell squamous carcinomas and sarcoma-like tumors of the skin: a comparative study of 38 cases. Cancer 1980 45 : 2687 97.
31. Broders AC. Squamous cell epithelioma of the skin. Ann Surg 1921 73 : 141 60.
32. Kirkham N. Tumors and cysts of the epidermis. In : Elder D, editor. Lever's histopathology of the skin. 9th ed. Philadelphia : Lippincott Williams & Wilkins 2005. p. 831.
33. Nappi O, Pettinato G, Wick MR. Adenoid (acantholytic) squamous cell carcinoma of the skin. J Cutan Pathol 1989 16 : 114 21.
34. Johnson WC, Helwig EB. Adenoid squamous cell carcinoma (adenoacanthoma): a clinicopathologic study of 155 patients. Cancer 1966 19 : 1639 50.
35. Kao GF. Carcinoma arising in Bowen's disease. Arch Dermatol 1986 122 : 1124 6.
36. Novick M, Gard DA, Hardy SB, et al. Burn scar carcinoma: a review and analysis of 46 cases. J Trauma 1977 17 : 809 17.
37. Dodd GD, Dolan PA, Ballantyne AJ, et al. The dissemination of tumors of the head and neck via the cranial nerves. Radiol Clin North Am 1970 88 : 445 61.
38. Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg 1984 148 : 542 7.
39. Byers RM, O'Brien J, Waxler J. The therapeutic and prognostic implications of nerve invasion in cancer of the lower lip. Int J Radiat Oncol Biol Phys 1978 4 : 215 7.
40. Dzubow LM, Rigel DS, Robins P. Risk factors for local recurrence of primary cutaneous squamous cell carcinoma: treatment by microscopically controlled excision. Arch Dermatol 1982 118 : 900 2.
41. Dinehart SM, Chu DZ, Maners AW, Pollack SV. Immunosuppression in patients with metastatic squamous cell carcinoma from the skin. J Dermatol Surg Oncol 1990 16 : 271 4.
42. Adamson R, Obispo E, Dychter S, et al. High incidence and clinical course of aggressive skin cancer in heart transplant patients: a single-center study. Transplant Proc 1998 30 : 1124 6.
43. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003 348 : 1681 91.
44. Ong CS, Keogh AM, Kossard S, et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999 40 : 27 34.
45. Jensen P, Hansen S, Moller B, et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999 40 : 177 86.
46. Euvrard S, Kanitakis J, Pouteil-Noble C, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995 33 (2 Pt 1) : 222 9.
47. Webb MC, Compton F, Andrews PA, Koffman CG. Skin tumours posttransplantation: a retrospective analysis of 28 years' experience at a single centre. Transplant Proc 1997 29 : 828 30.
48. Dantal J, Hourmant M, Cantarovich D, et al. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomized comparison of two cyclosporin regimens. Lancet 1998 351 : 623 8.
49. Meyer T, Ardnt R, Nindl I, et al. Association of human papillomavirus infections with cutaneous tumors in immunosuppressed patients. Transplant Int 2003 16 : 146 53.
50. Hojo M, Morimoto T, Maluccio M, et al. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999 397 : 530 4.
51. Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004 30 (4 Pt 2) : 624 41.
52. Carucci JA, Martinez JC, Zeitouni NC, et al. In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients: clinical characteristics, management, and outcome in a series of 21 patients. Dermatol Surg 2004 30 (4 Pt 2) : 651 5.
53. Bouwes Bavinck JN, Hardie DR, Green A, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996 61 : 715 21.
54. Espana A, Martinez-Gonzalez MA, Garcia-Grenero M, et al. A prospective study of incident nonmelanoma skin cancer in heart transplant patients. 2000 115 : 1158 60.
55. Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA 1975 232 : 267 9.
56. Mehrany K, Byrd DR, Roenigk RK, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003 29 : 129 34.
57. Weimar VM, Ceilley RI, Geoken JA. Aggressive behavior of basal and squamous cell cancers in patients with chronic lymphocytic lymphoma or chronic lymphocytic leukemia. J Dermatol Surg Oncol 1979 5 : 609 14.
58. Frierson HF, Deutsch BD, Levine PA. Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988 19 : 1397 402.
59. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of basal cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Arch Dermatol 2004 140 : 985 8.
60. Mehrany K, Weenig RH, Pittelkow MR, et al. High recurrence rates of squamous cell carcinoma after Mohs surgery in patients with chronic lymphocytic leukemia. Dermatol Surg 2005 31 : 38 42.
61. Mehrany K, Weenig RH, Lee KK. Increased metastasis and mortality from cutaneous squamous cell carcinoma in patients with chronic lymphocytic leukemia [abstract]. Annual Meeting of the American College of Mohs Micrographic Surgery and Cutaneous Oncology; 2005; Atlanta, GA.
62. Smoller BR, Warnke RA. Cutaneous infiltrate of chronic lymphocytic leukemia and relationship to cutaneous epithelial neoplasms. J Cutan Pathol 1998 25 : 160 4.
63. Fitzpatrick PJ, Harwood AA. Acute epithelioma-an aggressive squamous cell carcinoma of the skin. Am J Clin Oncol 1985 8 : 468 71.
64. Storkel S, Reichert T, Reiffen KA, Wagner W. EGFR and PCNA expression in oral squamous cell carcinomas. A valuable tool in estimating the patient's prognosis. Eur J Cancer B Oral Oncol 1993 29B : 273 7.
65. Lewis FW, Shah M, Messenger AG, Thomas WE. Metastatic squamous cell carcinoma in a patient receiving PUVA. Lancet 1994 344 : 1157.
66. Palme CE, O'Brien CJ, Veness MJ, et al. Extent of parotid disease influences outcome in patients with metastatic cutaneous squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2003 129 : 750 3.
67. Audet N, Palme CE, Gullane PJ, et al. Cutaneous metastatic squamous cell carcinoma to the parotid gland: analysis and outcome. Head Neck 2004 26 : 727 32.
68. Andruchow JL, Veness MJ, Morgan GJ, et al. Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer 2006 106 : 1078 83.
69. Dinehart SM, Peterson S. Evaluation of the American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma and proposal of a new staging system. Dermatol Surg 2005 31 (11 Pt 1) : 1379 84.
70. Greene FL, Page DL, Fleming ID, et al., editors. AJCC cancer staging manual. 6th ed. New York : Springer Verlag 2002. p. 203 8.
71. Brierley JD, Greene FL, Sobin LH, Wittekind C. The "y" symbol: an important classification tool for neoadjuvant cancer treatment. Cancer 2006 106 : 2526 7.
72. Friedman M, Mafee MF, Pacella BF Jr., et al. Rationale for elective neck dissection in 1990. Laryngoscope 1990 100 : 54 9.
73. Yousem DM, Som PM, Hackney DB, et al. Central nodal necrosis and extracapsular neoplastic spread in cervical lymph nodes: MR imaging versus CT. Radiology 1992 182 : 753 9.
74. Ginsberg LE. MR imaging of perineural tumor spread. Magn Reson Imag Clin N Am 2002 10 : 511 25, vi.
75. Winer E, Pautke C, Link TM, et al. Comparison of 16-slice MSCT and MRI in the assessment of squamous cell carcinoma of the oral cavity. Eur J Radiol 2006 58 : 113 8.
76. Bailet JW, Abemayor E, Jabour BA, et al. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992 102 : 281 8.
77. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18F-FDG-PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998 25 : 1255 60.
78. Juweid ME, Cheson BD. Positron emission tomography and assessment of cancer therapy. N Engl J Med 2006 354 : 496 507.
79. Motley R, Kersey P, Lawrence C. Multiprofessional guidelines for the management of the patient with primary cutaneous squamous cell carcinoma. Br J Dermatol 2002 146 : 13 25.
80. Stasko T, Brown MD, Carucci JA, et al. Guidelines for the management of squamous cell carcinoma in organ transplant recipients. Dermatol Surg 2004 30 (4 Pt 2) : 642 50.
81. Mohs FE. Chemosurgery: microscopically controlled surgery for skin cancer, Vol. 59. Springfield (IL) : Charles C. Thomas 1978. p. 158 76.
82. Barrett TL, Greenway HT Jr., Massullo V, Carlson C. Treatment of basal cell carcinoma and squamous cell carcinoma with perineural invasion. Adv Dermatol 1993 8 : 277 304.
83. Weisberg NK, Bertagnolli MM, Becker DS. Combined sentinel lymphadenectomy and Mohs micrographic surgery for high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2000 43 : 483 8.
84. Veness MJ, Morgan GJ, Palme CE, Gebski V. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice. Laryngoscope 2005 115 : 870 5.
85. McCord MW, Mendenhall WM, Parsons JT, et al. Skin cancer of the head and neck with clinical perineural invasion. Int J Radiat Oncol Biol Phys 2000 47 : 89 93.
86. Taylor BW, Brant TA, Mendenhall NP, et al. Carcinoma of the skin metastatic to parotid area lymph nodes. Head Neck 1994 13 : 427 33.
87. Jol JA, van Velhuysen ML, Hilgers FJ, et al. Treatment results of regional metastasis from cutaneous head and neck squamous cell carcinoma. Eur J Surg Oncol 2002 29 : 81 6.
88. Martinez JC, Cook JL. Is there a role for elective lymph node dissection in the management of patients with high-risk squamous cell carcinoma? [abstract]. Annual Meeting of the American College of Mohs Micrographic Surgery and Cutaneous Oncology; 2005; Atlanta, GA.
89. Martinez JC, Otley CC, Euvrard S, et al. Complications of systemic retinoid therapy in organ transplant recipients with squamous cell carcinoma. Dermatol Surg 2004 30 (4 Pt 2) : 662 6.
90. Toma S, Boneeli L, Sartoris A, et al. 13-cis retinoic acid in head and neck cancer chemoprevention: results of a randomized trial from the Italian Head and Neck Chemoprevention Study Group. Oncol Rep 2004 11 : 1297 305.
91. Levine N, Moon TE, Cartmel B, et al. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double blinded controlled trial. Southwest Skin Cancer Prevention Study Group. Cancer Epidemiol Biomarkers Prev 1997 6 : 957 61.
92. De Graaf YG, Euvrard S, Bouwes Bavinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004 30 (4 Pt 2) : 656 61.
93. Lippman SM, Parkinson DR, Itri LM, et al. 13-cis-retinoic acid and interferon alpha-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst 1992 84 : 235 41.
94. Martin-Garcia RF. Imiquimod: an effective alternative for the treatment of invasive cutaneous squamous cell carcinoma. Dermatol Surg 2005 31 : 371 4.
95. Butler GJ, Neale R, Green AC, et al. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005 53 : 966 72.
96. Sadek H, Azli N, Wendling JL. Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-flourouracil, and bleomycin. Cancer 1990 66 : 1692 6.
97. Lavertu P, Adelstein DJ, Saxton JP, et al. Aggressive concurrent chemoradiotherapy for squamous cell head and neck cancer: an 8-year single-institution experience. Arch Otolaryngol Head Neck Surg 1999 125 : 142 8.
98. Wollina U, Hansel G, Koch A, Kostler E. Oral capecitabine and subcutaneous IFN-alpha in advanced squamous cell carcinoma of the skin. J Cancer Res Clin Oncol 2005 131 : 300 4.
99. Martinez JC, Otley CC, Okuno SH, et al. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations. Dermatol Surg 2004 30 (4 Pt 2) : 6790 686.
100. Cohen EE, Kane MA, List MA, et al. Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. Clin Cancer Res 2005 11 : 8418 24.